Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
iGEM and Gene Drives: A Case Study for Governance.
Millett P, Alexanian T, Palmer MJ, Evans SW, Kuiken T, Oye K. Millett P, et al. Among authors: oye k. Health Secur. 2022 Jan-Feb;20(1):26-34. doi: 10.1089/hs.2021.0157. Epub 2022 Jan 11. Health Secur. 2022. PMID: 35020492 Free PMC article.
A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem.
Selker HP, Cohen T, D'Agostino RB, Dere WH, Ghaemi SN, Honig PK, Kaitin KI, Kaplan HC, Kravitz RL, Larholt K, McElwee NE, Oye KA, Palm ME, Perfetto E, Ramanathan C, Schmid CH, Seyfert-Margolis V, Trusheim M, Eichler HG. Selker HP, et al. Among authors: oye ka. Clin Pharmacol Ther. 2022 Aug;112(2):224-232. doi: 10.1002/cpt.2425. Epub 2021 Oct 20. Clin Pharmacol Ther. 2022. PMID: 34551122 Free PMC article. Review.
Emerging Biotechnology and Information Hazards.
Nieuwenweg AC, Trump BD, Klasa K, Bleijs DA, Oye KA. Nieuwenweg AC, et al. Among authors: oye ka. 2021 Sep 8. In: Trump BD, Florin MV, Perkins E, Linkov I, editors. Emerging Threats of Synthetic Biology and Biotechnology: Addressing Security and Resilience Issues [Internet]. Dordrecht (DE): Springer; 2021. Chapter 9. 2021 Sep 8. In: Trump BD, Florin MV, Perkins E, Linkov I, editors. Emerging Threats of Synthetic Biology and Biotechnology: Addressing Security and Resilience Issues [Internet]. Dordrecht (DE): Springer; 2021. Chapter 9. PMID: 36122103 Free Books & Documents. Review.
Core commitments for field trials of gene drive organisms.
Long KC, Alphey L, Annas GJ, Bloss CS, Campbell KJ, Champer J, Chen CH, Choudhary A, Church GM, Collins JP, Cooper KL, Delborne JA, Edwards OR, Emerson CI, Esvelt K, Evans SW, Friedman RM, Gantz VM, Gould F, Hartley S, Heitman E, Hemingway J, Kanuka H, Kuzma J, Lavery JV, Lee Y, Lorenzen M, Lunshof JE, Marshall JM, Messer PW, Montell C, Oye KA, Palmer MJ, Papathanos PA, Paradkar PN, Piaggio AJ, Rasgon JL, Rašić G, Rudenko L, Saah JR, Scott MJ, Sutton JT, Vorsino AE, Akbari OS. Long KC, et al. Among authors: oye ka. Science. 2020 Dec 18;370(6523):1417-1419. doi: 10.1126/science.abd1908. Science. 2020. PMID: 33335055 No abstract available.
Building biosecurity for synthetic biology.
Trump BD, Galaitsi SE, Appleton E, Bleijs DA, Florin MV, Gollihar JD, Hamilton RA, Kuiken T, Lentzos F, Mampuys R, Merad M, Novossiolova T, Oye K, Perkins E, Garcia-Reyero N, Rhodes C, Linkov I. Trump BD, et al. Among authors: oye k. Mol Syst Biol. 2020 Jul;16(7):e9723. doi: 10.15252/msb.20209723. Mol Syst Biol. 2020. PMID: 32692486 Free PMC article.
Efficacy and Effectiveness Too Trials: Clinical Trial Designs to Generate Evidence on Efficacy and on Effectiveness in Wide Practice.
Selker HP, Eichler HG, Stockbridge NL, McElwee NE, Dere WH, Cohen T, Erban JK, Seyfert-Margolis VL, Honig PK, Kaitin KI, Oye KA, D'Agostino RB Sr. Selker HP, et al. Among authors: oye ka. Clin Pharmacol Ther. 2019 Apr;105(4):857-866. doi: 10.1002/cpt.1347. Epub 2019 Feb 12. Clin Pharmacol Ther. 2019. PMID: 30610746 Free PMC article.
Considerations for the governance of gene drive organisms.
Rudenko L, Palmer MJ, Oye K. Rudenko L, et al. Among authors: oye k. Pathog Glob Health. 2018 Jun;112(4):162-181. doi: 10.1080/20477724.2018.1478776. Epub 2018 Jul 5. Pathog Glob Health. 2018. PMID: 29975593 Free PMC article. Review.
26 results